ACTAVIA LIFE SCIENCES, INC. Quarterly Debt-to-equity in % from Q3 2014 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Actavia Life Sciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2014 to Q3 2023.
  • Actavia Life Sciences, Inc. Debt-to-equity for the quarter ending September 30, 2023 was -103 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 -103 Sep 30, 2023
Q2 2023 -103 Jun 30, 2023
Q3 2021 -102 -747 -116% Sep 30, 2021
Q2 2021 -102 -251 -168% Jun 30, 2021
Q1 2021 -127 -230 -224% Mar 31, 2021
Q4 2020 -298 -394 -411% Dec 31, 2020
Q3 2020 645 +554 +610% Sep 30, 2020
Q2 2020 149 +65.4 +78.3% Jun 30, 2020
Q1 2020 103 +31.4 +44.1% Mar 31, 2020
Q4 2019 95.9 +39.8 +70.8% Dec 31, 2019
Q3 2019 90.8 +48.9 +117% Sep 30, 2019
Q2 2019 83.6 +51.4 +160% Jun 30, 2019
Q1 2019 71.2 +44.3 +164% Mar 31, 2019
Q4 2018 56.2 +32.4 +136% Dec 31, 2018
Q3 2018 41.9 +7.66 +22.4% Sep 30, 2018
Q2 2018 32.2 -9.82 -23.4% Jun 30, 2018
Q1 2018 27 -6.88 -20.3% Mar 31, 2018
Q4 2017 23.8 -16 -40.2% Dec 31, 2017
Q3 2017 34.2 +7.14 +26.4% Sep 30, 2017
Q2 2017 42 +34.2 +440% Jun 30, 2017
Q1 2017 33.8 -20.1 -37.3% Mar 31, 2017
Q4 2016 39.8 +36.9 +1262% Dec 31, 2016
Q3 2016 27.1 +25 +1189% Sep 30, 2016
Q2 2016 7.78 +6.4 +464% Jun 30, 2016
Q1 2016 54 +53.1 +6301% Mar 31, 2016
Q4 2015 2.92 +2.75 +1651% Dec 31, 2015
Q3 2015 2.1 +1.97 +1558% Sep 30, 2015
Q2 2015 1.38 Jun 30, 2015
Q1 2015 0.84 Mar 31, 2015
Q4 2014 0.17* Dec 31, 2014
Q3 2014 0.13* Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.